274 related articles for article (PubMed ID: 38664425)
1. Effects of microbiome-based interventions on neurodegenerative diseases: a systematic review and meta-analysis.
Chui ZSW; Chan LML; Zhang EWH; Liang S; Choi EPH; Lok KYW; Tun HM; Kwok JYY
Sci Rep; 2024 Apr; 14(1):9558. PubMed ID: 38664425
[TBL] [Abstract][Full Text] [Related]
2. The Role of Fecal Microbiota Transplantation in the Treatment of Neurodegenerative Diseases: A Review.
Matheson JT; Holsinger RMD
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674517
[TBL] [Abstract][Full Text] [Related]
3. Modulation of gut microbiome in the treatment of neurodegenerative diseases: A systematic review.
Mincic AM; Antal M; Filip L; Miere D
Clin Nutr; 2024 Jul; 43(7):1832-1849. PubMed ID: 38878554
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbial Metabolome and Dysbiosis in Neurodegenerative Diseases: Psychobiotics and Fecal Microbiota Transplantation as a Therapeutic Approach-A Comprehensive Narrative Review.
Uceda S; Echeverry-Alzate V; Reiriz-Rojas M; Martínez-Miguel E; Pérez-Curiel A; Gómez-Senent S; Beltrán-Velasco AI
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686104
[TBL] [Abstract][Full Text] [Related]
5. A Systematic Review and Meta-analysis of Dietary Interventions Modulating Gut Microbiota and Cardiometabolic Diseases-Striving for New Standards in Microbiome Studies.
Attaye I; Warmbrunn MV; Boot ANAF; van der Wolk SC; Hutten BA; Daams JG; Herrema H; Nieuwdorp M
Gastroenterology; 2022 Jun; 162(7):1911-1932. PubMed ID: 35151697
[TBL] [Abstract][Full Text] [Related]
6. [Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation].
Aitbaev KA; Murkamilov IT; Fomin VV
Ter Arkh; 2017; 89(8):120-128. PubMed ID: 28914862
[TBL] [Abstract][Full Text] [Related]
7. Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care.
Ciernikova S; Sevcikova A; Drgona L; Mego M
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188990. PubMed ID: 37742728
[TBL] [Abstract][Full Text] [Related]
8. The dichotomous role of the gut microbiome in exacerbating and ameliorating neurodegenerative disorders.
Raval U; Harary JM; Zeng E; Pasinetti GM
Expert Rev Neurother; 2020 Jul; 20(7):673-686. PubMed ID: 32459513
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.
Metta V; Leta V; Mrudula KR; Prashanth LK; Goyal V; Borgohain R; Chung-Faye G; Chaudhuri KR
J Neurol; 2022 Mar; 269(3):1154-1163. PubMed ID: 33881598
[TBL] [Abstract][Full Text] [Related]
10. Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis.
Westfall S; Lomis N; Kahouli I; Dia SY; Singh SP; Prakash S
Cell Mol Life Sci; 2017 Oct; 74(20):3769-3787. PubMed ID: 28643167
[TBL] [Abstract][Full Text] [Related]
11. Gut-Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders.
Toledo ARL; Monroy GR; Salazar FE; Lee JY; Jain S; Yadav H; Borlongan CV
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163103
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL#3 for active ulcerative colitis: A systematic review and meta-analysis.
Dang X; Xu M; Liu D; Zhou D; Yang W
PLoS One; 2020; 15(3):e0228846. PubMed ID: 32182248
[TBL] [Abstract][Full Text] [Related]
14. Probiotics, prebiotics, synbiotics, and fecal microbiota transplantation in the treatment of behavioral symptoms of autism spectrum disorder: A systematic review.
Tan Q; Orsso CE; Deehan EC; Kung JY; Tun HM; Wine E; Madsen KL; Zwaigenbaum L; Haqq AM
Autism Res; 2021 Sep; 14(9):1820-1836. PubMed ID: 34173726
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease: Are gut microbes involved?
Omotosho AO; Tajudeen YA; Oladipo HJ; Yusuff SI; AbdulKadir M; Muili AO; Egbewande OM; Yusuf RO; Faniran ZO; Afolabi AO; El-Sherbini MS
Brain Behav; 2023 Aug; 13(8):e3130. PubMed ID: 37340511
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal Microbiome and Multiple Health Outcomes: Umbrella Review.
Chang C; Yuan X; Zhang X; Chen X; Li K
Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145102
[TBL] [Abstract][Full Text] [Related]
17. Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders.
Zheng Y; Bonfili L; Wei T; Eleuteri AM
Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960284
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota in neurodegenerative disorders.
Roy Sarkar S; Banerjee S
J Neuroimmunol; 2019 Mar; 328():98-104. PubMed ID: 30658292
[TBL] [Abstract][Full Text] [Related]
19. The impact of modulating the gastrointestinal microbiota in cancer patients.
Morkūnas E; Skiecevičienė J; Kupčinskas J
Best Pract Res Clin Gastroenterol; 2020; 48-49():101700. PubMed ID: 33317795
[TBL] [Abstract][Full Text] [Related]
20. The Microbiome as a Modifier of Neurodegenerative Disease Risk.
Fang P; Kazmi SA; Jameson KG; Hsiao EY
Cell Host Microbe; 2020 Aug; 28(2):201-222. PubMed ID: 32791113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
